PL2451943T3 - Sposoby i kompozycje do zastosowania w terapiach komórkowych - Google Patents
Sposoby i kompozycje do zastosowania w terapiach komórkowychInfo
- Publication number
- PL2451943T3 PL2451943T3 PL10752171T PL10752171T PL2451943T3 PL 2451943 T3 PL2451943 T3 PL 2451943T3 PL 10752171 T PL10752171 T PL 10752171T PL 10752171 T PL10752171 T PL 10752171T PL 2451943 T3 PL2451943 T3 PL 2451943T3
- Authority
- PL
- Poland
- Prior art keywords
- compositions
- methods
- cellular therapies
- therapies
- cellular
- Prior art date
Links
- 238000002659 cell therapy Methods 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0662—Stem cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0662—Stem cells
- C12N5/0667—Adipose-derived stem cells [ADSC]; Adipose stromal stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K2035/122—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells for inducing tolerance or supression of immune responses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Developmental Biology & Embryology (AREA)
- Immunology (AREA)
- General Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biotechnology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cell Biology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Rheumatology (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Virology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Neurology (AREA)
- Hematology (AREA)
- Neurosurgery (AREA)
- Dermatology (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Transplantation (AREA)
- Nutrition Science (AREA)
- Psychiatry (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US22427509P | 2009-07-09 | 2009-07-09 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2451943T3 true PL2451943T3 (pl) | 2017-04-28 |
Family
ID=42782196
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL10752171T PL2451943T3 (pl) | 2009-07-09 | 2010-07-09 | Sposoby i kompozycje do zastosowania w terapiach komórkowych |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US8679834B2 (cg-RX-API-DMAC7.html) |
| EP (2) | EP2451943B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP5892931B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR101788885B1 (cg-RX-API-DMAC7.html) |
| CN (2) | CN107007626A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2010269962B2 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112012000534A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2767300C (cg-RX-API-DMAC7.html) |
| DK (1) | DK2451943T3 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2479542T3 (cg-RX-API-DMAC7.html) |
| HU (1) | HUE031921T2 (cg-RX-API-DMAC7.html) |
| IL (1) | IL217377A (cg-RX-API-DMAC7.html) |
| MX (1) | MX359639B (cg-RX-API-DMAC7.html) |
| NZ (1) | NZ597975A (cg-RX-API-DMAC7.html) |
| PL (1) | PL2451943T3 (cg-RX-API-DMAC7.html) |
| PT (1) | PT2451943T (cg-RX-API-DMAC7.html) |
| RU (1) | RU2610427C2 (cg-RX-API-DMAC7.html) |
| SG (2) | SG177582A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2011004264A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060045872A1 (en) | 2004-08-25 | 2006-03-02 | Universidad Autonoma De Madrid Ciudad Universitaria de Cantoblanco | Use of adipose tissue-derived stromal stem cells in treating fistula |
| ES2589311T5 (es) | 2005-09-23 | 2020-02-14 | Tigenix S A U | Poblaciones de células que tienen actividad inmunorreguladora, método de aislamiento y usos |
| US11090363B2 (en) | 2009-07-10 | 2021-08-17 | University of Pittsburgh—of the Commonwealth System of Higher Education | Vasoactive intestinal peptide release from microparticles |
| US8846098B2 (en) | 2009-07-10 | 2014-09-30 | University Of Pittsburgh-Of The Commonwealth System Of Higher Education | Artificial cell constructs for cellular manipulation |
| EP2663316A2 (en) * | 2011-01-12 | 2013-11-20 | TiGenix, S.A.U. | Adipose-derived mesenchymal stem cells for intralymphatic administration in autoimmune and inflammatory diseases |
| CA2857545A1 (en) | 2011-11-30 | 2013-06-06 | Advanced Cell Technology, Inc. | Mesenchymal stromal cells and uses related thereto |
| US8961956B2 (en) | 2011-11-30 | 2015-02-24 | Ocata Therapeutics, Inc. | Mesenchymal stromal cells and uses related thereto |
| EP2833896A2 (en) * | 2012-03-30 | 2015-02-11 | University Of Southern California | Compositions and treatment methods for mesenchymal stem cell-induced immunoregulation |
| WO2014011407A2 (en) | 2012-07-12 | 2014-01-16 | Imstem Biotechnology, Inc. | Mesenchymal-like stem cells derived from human embryonic stem cells, methods and uses thereof |
| US10258652B2 (en) | 2014-12-18 | 2019-04-16 | Pluristem Ltd. | Methods and compositions for treating and preventing muscle wasting disorders |
| WO2016107563A1 (zh) * | 2014-12-29 | 2016-07-07 | 西比曼生物科技（上海）有限公司 | 一种用于治疗上呼吸道疾病的脂肪间充质祖细胞复合物 |
| IL294058A (en) | 2015-03-23 | 2022-08-01 | Pluristem Ltd | Use of adherent stromal cells for enhancing hematopoiesis in a subject in need thereof |
| AU2017220148A1 (en) | 2016-02-18 | 2018-07-19 | Pluristem Ltd. | Methods and compositions for treating cancers and neoplasms |
| GB201604304D0 (en) | 2016-03-14 | 2016-04-27 | Tigenix S A U | Adipose tissue-derived stromal stem cells for use in treating refractory complex perianal fistulas in crohn's disease |
| US12161688B2 (en) | 2016-06-30 | 2024-12-10 | Mapi Pharma Ltd | Treatment of inflammatory bowel disease with long acting glatiramer and adipose-derived stem cells |
| AU2017414803B2 (en) | 2017-05-15 | 2025-02-13 | Mapi Pharma Ltd. | Treatment of multiple sclerosis with long acting glatiramer and adipose-derived stem cells |
| WO2018211498A1 (en) | 2017-05-15 | 2018-11-22 | Stem Cell Medicine Ltd. | Treatment of multiple sclerosis with adipose-derived stem cells |
| CN107281469A (zh) * | 2017-07-17 | 2017-10-24 | 广东颜值科技有限公司 | 一种细胞组合物及其制备方法和应用 |
| CN107349419A (zh) * | 2017-07-17 | 2017-11-17 | 广东颜值科技有限公司 | 一种细胞组合物及其制备方法和应用 |
| US12268714B2 (en) | 2018-09-14 | 2025-04-08 | Luca Science Inc. | Transplantation of mitochondria into lymphoid organ and composition therefor |
| JP2022527455A (ja) * | 2019-03-19 | 2022-06-02 | フィジーン、エルエルシー | 活性化線維芽細胞及びそのエキソソーム誘導体を用いた慢性閉塞性肺疾患及び肺変性の治療 |
| WO2020243504A1 (en) * | 2019-05-31 | 2020-12-03 | Figene, Llc | Concurrent activation of regenerative and tolerogenic processes by fibroblast-based compositions for the treatment of multiple sclerosis |
| US20240000850A1 (en) * | 2020-04-08 | 2024-01-04 | Figene, Llc | Methods and compositions for allergy and asthma treatment using fibroblasts |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE60334474D1 (de) * | 2002-07-12 | 2010-11-18 | Univ Johns Hopkins | Reagenzien und verfahren zum eingriff in einzigartige klonotype lymphozyten-rezeptoren |
| CN1738619B (zh) * | 2002-12-06 | 2012-04-18 | 西北生物治疗药物公司 | 给予体外部分成熟的树突细胞治疗肿瘤的制药用途 |
| ES2589311T5 (es) | 2005-09-23 | 2020-02-14 | Tigenix S A U | Poblaciones de células que tienen actividad inmunorreguladora, método de aislamiento y usos |
| US8241621B2 (en) * | 2006-12-18 | 2012-08-14 | Medistem Laboratories | Stem cell mediated treg activation/expansion for therapeutic immune modulation |
| AU2008287063B2 (en) * | 2007-08-09 | 2013-10-24 | Genzyme Corporation | Method of treating autoimmune disease with mesenchymal stem cells |
| JPWO2009031606A1 (ja) * | 2007-09-07 | 2010-12-16 | 日本ケミカルリサーチ株式会社 | 関節炎治療及び予防剤 |
| EP2279246A4 (en) * | 2008-05-02 | 2012-03-28 | Massachusetts Inst Technology | METHOD AND COMPOSITIONS FOR MODULATING IMMUNOLOGICAL TOLERANCE |
| GB0814249D0 (en) * | 2008-08-04 | 2008-09-10 | Cellerix Sa | Uses of mesenchymal stem cells |
-
2010
- 2010-07-09 EP EP10752171.8A patent/EP2451943B1/en active Active
- 2010-07-09 BR BR112012000534A patent/BR112012000534A2/pt not_active Application Discontinuation
- 2010-07-09 KR KR1020127003364A patent/KR101788885B1/ko active Active
- 2010-07-09 HU HUE10752171A patent/HUE031921T2/en unknown
- 2010-07-09 SG SG2012001574A patent/SG177582A1/en unknown
- 2010-07-09 EP EP16199980.0A patent/EP3150703A1/en not_active Withdrawn
- 2010-07-09 US US13/382,426 patent/US8679834B2/en active Active
- 2010-07-09 JP JP2012519080A patent/JP5892931B2/ja active Active
- 2010-07-09 RU RU2012104529A patent/RU2610427C2/ru active
- 2010-07-09 PT PT107521718T patent/PT2451943T/pt unknown
- 2010-07-09 WO PCT/IB2010/001968 patent/WO2011004264A1/en not_active Ceased
- 2010-07-09 NZ NZ597975A patent/NZ597975A/en unknown
- 2010-07-09 CN CN201710067652.0A patent/CN107007626A/zh active Pending
- 2010-07-09 SG SG10201403758SA patent/SG10201403758SA/en unknown
- 2010-07-09 DK DK10752171.8T patent/DK2451943T3/en active
- 2010-07-09 AU AU2010269962A patent/AU2010269962B2/en active Active
- 2010-07-09 MX MX2012000396A patent/MX359639B/es active IP Right Grant
- 2010-07-09 PL PL10752171T patent/PL2451943T3/pl unknown
- 2010-07-09 ES ES10752171.8T patent/ES2479542T3/es active Active
- 2010-07-09 CA CA2767300A patent/CA2767300C/en active Active
- 2010-07-09 CN CN2010800308900A patent/CN102549147A/zh active Pending
-
2012
- 2012-01-05 IL IL217377A patent/IL217377A/en active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| RU2012104529A (ru) | 2013-08-20 |
| JP2012532859A (ja) | 2012-12-20 |
| KR20120051006A (ko) | 2012-05-21 |
| EP2451943B1 (en) | 2016-11-23 |
| MX359639B (es) | 2018-10-04 |
| US8679834B2 (en) | 2014-03-25 |
| WO2011004264A1 (en) | 2011-01-13 |
| RU2610427C2 (ru) | 2017-02-10 |
| US20120308585A1 (en) | 2012-12-06 |
| NZ597975A (en) | 2014-06-27 |
| IL217377A0 (en) | 2012-02-29 |
| IL217377A (en) | 2017-10-31 |
| PT2451943T (pt) | 2017-01-20 |
| CN107007626A (zh) | 2017-08-04 |
| BR112012000534A2 (pt) | 2017-06-13 |
| AU2010269962A1 (en) | 2012-03-01 |
| EP2451943A1 (en) | 2012-05-16 |
| DK2451943T3 (en) | 2017-02-06 |
| JP5892931B2 (ja) | 2016-03-23 |
| EP3150703A1 (en) | 2017-04-05 |
| CA2767300C (en) | 2020-01-07 |
| SG10201403758SA (en) | 2014-10-30 |
| AU2010269962B2 (en) | 2016-04-14 |
| CA2767300A1 (en) | 2011-01-13 |
| HUE031921T2 (en) | 2017-08-28 |
| MX2012000396A (es) | 2012-07-17 |
| ES2479542T3 (es) | 2017-05-26 |
| KR101788885B1 (ko) | 2017-10-20 |
| CN102549147A (zh) | 2012-07-04 |
| SG177582A1 (en) | 2012-03-29 |
| ES2479542T1 (es) | 2014-08-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG10201403758SA (en) | Methods and compositions for use in cellular therapies | |
| PT2272339E (pt) | Métodos e composições para utilização com dispensadores de gel | |
| IL219891A0 (en) | Lipopeptide compositions and related methods | |
| PH12013500698A1 (en) | Hair-mending compositions and associated methods | |
| IL218212A0 (en) | Therapeutic methods and compositions | |
| GB0903299D0 (en) | Composition and methods | |
| ZA201206718B (en) | Pde10 inhibitors and related compositions and methods | |
| SG10201609184PA (en) | Compositions and methods for extended therapy with aminopyridines | |
| ZA201202561B (en) | Compositions and methods for enhancing cognitive and related functions in animals | |
| EP2410990A4 (en) | COMPOSITIONS AND METHODS FOR CONTRAST GAINING IN IMAGING | |
| EP2601269A4 (en) | ANTI-ABSORPTION COMPOSITIONS AND METHOD FOR THEIR USE | |
| GB201018650D0 (en) | Methods and compositions | |
| EP2205271A4 (en) | COMPOSITIONS AND METHODS OF THERAPIES BASED ON RIBONUCLEASE BASE | |
| ZA201305086B (en) | Methods and compositions useful for promoting sleep in animals | |
| GB0901494D0 (en) | Compositions and Methods | |
| EP2461870A4 (en) | THERAPEUTIC COMPOSITIONS AND METHOD | |
| GB2475090B (en) | Fuels, methods of making them and additives for use in fuels | |
| ZA201201369B (en) | Improvements in and relating to cable-barriers | |
| EP2498606A4 (en) | TIVOZANIB AND TEMSIROLIMUS IN COMBINATION | |
| EP2723349A4 (en) | MICROARN-31 COMPOSITIONS AND METHODS OF USE IN AUTOIMMUNE DISEASES | |
| GB0900329D0 (en) | Improvements in anti-ligature devices and methods | |
| GB0919726D0 (en) | Methods and molecules for use in immunotherapy | |
| GB0908498D0 (en) | Compositions and methods | |
| GB0903913D0 (en) | Compositions and methods | |
| GB0907616D0 (en) | Methods and compositions |